Trial Profile
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Aug 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 14 Jun 2018 Status changed from active, no longer recruiting to completed.
- 03 Jan 2018 Planned End Date changed from 30 Nov 2017 to 26 Apr 2018.
- 12 Oct 2017 Planned End Date changed from 15 Jun 2017 to 30 Nov 2017.